Loading clinical trials...
Loading clinical trials...
Pregabalin for the Treatment of Abdominal Pain From Adhesions: Placebo Controlled Trial
Conditions
Interventions
Pregabalin 75 or 150 mg BID for 7 weeks followed by open label pregabalin 150 mg BID for 4 weeks
Placebo first followed by open label pregabalin
Locations
1
United States
Henry Ford Health System
West Bloomfield, Michigan, United States
Start Date
March 1, 2006
Primary Completion Date
August 1, 2008
Completion Date
August 1, 2008
Last Updated
October 23, 2023
NCT03823742
NCT07008092
NCT06315179
NCT06268964
NCT05725967
NCT07164651
Lead Sponsor
Henry Ford Health System
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions